Professor Clarke holds a chair in Clinical Neurology at the University of Birmingham, UK. He moved from a post as Consultant Neurologist and Head of Department at Hull Royal Infirmary in 1999.
He has performed a wide variety of research work in Parkinson’s disease over the last 25 years. This includes work on the MPTP primate model of the condition, examination of several potential diagnostic tests, systematic reviews of clinical trials in Parkinson’s disease, and work on the affect of Parkinson’s disease on quality of life and health economics.
He is currently involved in several large pragmatic clinical trials examining medical, surgical and rehabilitation interventions in the condition (PD MED, PD SURG, PD REHAB, PD COMM and PD GEN). He was also the clinical advisor to the Technical Team preparing the NICE Parkinson’s disease guidelines.
He is Director of Research and Development for the Trust and is chair of the British and Irish Neurologists’ Movement Disorders Group, the British Movement Disorders Group, and the Association of British Neurologists Movement Disorders Section. He sits on the NIHR Efficacy and Mechanisms Evaluation (EME) Board and is a founding editor of the Cochrane Movement Disorders Group.
Via secretary: Linda Gardiner – 0121 507 4073